Literature DB >> 35871348

Costs of Persons with Dementia Living in Nursing Homes in The Netherlands.

Philip Charles Gerard Klein1, Simone Huygens1, Ron Handels2, Valérie Wester1, Tim Andre Kanters1.   

Abstract

BACKGROUND: Disease modifying treatments (DMTs) currently under development for Alzheimer's disease, have the potential to prevent or postpone institutionalization and more expensive care and might delay institutionalization of persons with dementia.
OBJECTIVE: The current study estimates costs of living in a nursing home for persons with dementia in the Netherlands to help inform economic evaluations of future DMTs.
METHODS: Data were collected during semi-structured interviews with healthcare professionals and from the financial administration of a healthcare organization with several nursing homes. Personnel costs were calculated using a bottom-up approach by valuing the time estimates. Non-personnel costs were calculated using information from the financial administration of the healthcare organization.
RESULTS: Total costs of a person with dementia per 24 hours, including both care staff and other healthcare providers, were € 151 for small-scale living wards and € 147 for independent living wards. Non-personnel costs were € 37 per day.
CONCLUSION: This study provides Dutch estimates for total healthcare costs per day for institutionalized persons with dementia. These cost estimates can be used in cost-effectiveness analyses for future DMTs in dementia.

Entities:  

Keywords:  Dementia; health care economics and organizations; health resources; nursing homes

Mesh:

Year:  2022        PMID: 35871348      PMCID: PMC9535598          DOI: 10.3233/JAD-220416

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.160


  14 in total

1.  What do international pharmacoeconomic guidelines say about economic data transferability?

Authors:  Marco Barbieri; Michael Drummond; Frans Rutten; John Cook; Henry A Glick; Joanna Lis; Shelby D Reed; Mark Sculpher; Johan L Severens
Journal:  Value Health       Date:  2010-12       Impact factor: 5.725

2.  Costs of care for people with dementia just before and after nursing home placement: primary data from eight European countries.

Authors:  Ansgar Wübker; Sandra M G Zwakhalen; David Challis; Riitta Suhonen; Staffan Karlsson; Adelaida Zabalegui; Maria Soto; Kai Saks; Dirk Sauerland
Journal:  Eur J Health Econ       Date:  2014-07-29

3.  Assessing cost-effectiveness of early intervention in Alzheimer's disease: An open-source modeling framework.

Authors:  Colin Green; Ron Handels; Anders Gustavsson; Anders Wimo; Bengt Winblad; Anders Sköldunger; Linus Jönsson
Journal:  Alzheimers Dement       Date:  2019-08-08       Impact factor: 21.566

4.  Risk factors for burnout among caregivers working in nursing homes.

Authors:  Nadia Kandelman; Thierry Mazars; Antonin Levy
Journal:  J Clin Nurs       Date:  2017-07-17       Impact factor: 3.036

5.  Cost of dementia in the pre-enlargement countries of the European Union.

Authors:  Ramon Luengo-Fernandez; Jose Leal; Alastair M Gray
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 6.  The main cost drivers in dementia: a systematic review.

Authors:  Sandra Schaller; Josephine Mauskopf; Christine Kriza; Philip Wahlster; Peter L Kolominsky-Rabas
Journal:  Int J Geriatr Psychiatry       Date:  2014-10-16       Impact factor: 3.485

7.  Mortality and treatment costs have a great impact on the cost-effectiveness of disease modifying treatment in Alzheimer's disease--a simulation study.

Authors:  Anders Sköldunger; Kristina Johnell; Bengt Winblad; Anders Wimo
Journal:  Curr Alzheimer Res       Date:  2013-02       Impact factor: 3.498

Review 8.  The cost of dementia in Europe: a review of the evidence, and methodological considerations.

Authors:  Linus Jönsson; Anders Wimo
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

9.  Impact of early intervention and disease modification in patients with predementia Alzheimer's disease: a Markov model simulation.

Authors:  David Budd; Leah C Burns; Zhenchao Guo; Gilbert L'italien; Pablo Lapuerta
Journal:  Clinicoecon Outcomes Res       Date:  2011-10-07

10.  Quantifying and Describing the Natural History and Costs of Alzheimer's Disease and Effects of Hypothetical Interventions.

Authors:  Anders Wimo; Ron Handels; Bengt Winblad; Christopher M Black; Gunilla Johansson; Stina Salomonsson; Maria Eriksdotter; Rezaul K Khandker
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.